Endothelial dysfunction and enhanced contractility in microvessels from ovariectomized rats roles of oxidative stress and perivascular adipose tissue

Hypertension

Volumn 63, Issue 5, 2014, Pages 1063-1069

  Wang, Dan ^a   Wang, Cheng ^c   Wu, Xie ^b   Zheng, Wei ^b   Sandberg, Kathryn ^b   Ji, Hong ^b   Welch, William J ^a   Wilcox, Christopher S ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Menopause; Nitric oxide; Ovariectomy; Reactive oxygen species; Tempol; Thromboxane prostanoid receptors

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE REGULATORY SUBUNIT P22; NITRIC OXIDE; PHENYLEPHRINE; PROSTANOID RECEPTOR; PROTEIN P22; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TEMPOL; THROMBOXANE RECEPTOR; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; MICROVASCULATURE; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; VASOCONSTRICTION; VASODILATATION; WESTERN BLOTTING;

MENOPAUSE; NITRIC OXIDE; OVARIECTOMY; REACTIVE OXYGEN SPECIES; TEMPOL; THROMBOXANE PROSTANOID RECEPTORS;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETYLCHOLINE; ADIPOSE TISSUE; ANIMALS; CYCLIC N-OXIDES; ENDOTHELIUM, VASCULAR; FEMALE; MICROVESSELS; MODELS, ANIMAL; NITRIC OXIDE; OVARIECTOMY; OXIDATIVE STRESS; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SPIN LABELS; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 84902268296     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02284     Document Type: Article

References (35)

1. Mendelsohn ME, Karas RH The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999; 340: 1801-1811. (Pubitemid 29266405)
2. Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med. 1993; 329: 247-256. (Pubitemid 23203817)
3. Lam KK, Lee YM, Hsiao G, Chen S Y, Yen MH Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariec-tomized rats. Menopause. 2006; 13: 294-302.
4. Wassmann S, Bäumer AT, Strehlow K., van Eickels M, Grohé C, Ahlbory K, Rösen R, Böhm M, Nickenig G. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation. 2001; 103: 435-441. (Pubitemid 32105985)
5. Wang D, Luo Z, Wang X., Jose PA, Falck Jr, Welch WJ, Aslam S, Teerlink T., Wilcox CS. Impaired endothelial function and microvascular asymmetrical dimethylarginine in angiotensin II-infused rats: effects of tempol. Hypertension. 2010; 56: 950-955.
6. Davidge ST, Zhang Y. Estrogen replacement suppresses a prostaglandin H synthase-dependent vasoconstrictor in rat mesenteric arteries. Circ Res. 1998; 83: 388-395. (Pubitemid 28389968)
7. Thompson LP, Weiner CP Long-term estradiol replacement decreases contractility of guinea pig coronary arteries to the thromboxane mimetic U46619. Circulation. 1997; 95: 709-714. (Pubitemid 27063049)
8. Calkin AC, Sudhir K, Honisett S., Williams MR, Dawood T, Komesaroff PA Rapid potentiation of endothelium-dependent vasodilation by estra-diol in postmenopausal women is mediated via cyclooxygenase 2. J Clin Endocrinol Metab. 2002; 87: 5072-5075. (Pubitemid 35316348)
9. Yusuf S, Hawken S, Ounpuu S., Dans T, Avezum A, Lanas F., McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937-952. (Pubitemid 39208455)
10. Shi H, Clegg DJ Sex differences in the regulation of body weight. Physiol Behav. 2009; 97: 199-204.
11. Brown LM, Gent L, Davis K., Clegg DJ Metabolic impact of sex hormones on obesity. Brain Res. 2010; 1350: 77-85.
12. Gao YJ, Lu C, Su L.Y., Sharma AM, Lee RM Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol. 2007; 151: 323-331. (Pubitemid 46842669)
13. Lee RM, Lu C, Su L.Y., Gao YJ Endothelium-dependent relaxation factor released by perivascular adipose tissue. J Hypertens. 2009; 27: 782-790.
14. Vacek TP, Gillespie W, Tyagi N., Vacek JC, Tyagi SC Hydrogen sulfide protects against vascular remodeling from endothelial damage. Amino Acids. 2010; 39: 1161-1169.
15. Gálvez-Prieto B., Dubrovska G, Cano M.V., Delgado M., Aranguez I, González MC, Ruiz-Gayo M, Gollasch M., Fernández-Alfonso MS. A reduction in the amount and anti-contractile effect of periadventitial mes-enteric adipose tissue precedes hypertension development in spontaneously hypertensive rats. Hypertens Res. 2008; 31: 1415-1423.
16. Marchesi C, Ebrahimian T, Angulo O., Paradis P, Schiffrin EL Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension. 2009; 54: 1384-1392.
17. Greenstein AS, Khavandi K, Withers S.B., Sonoyama K., Clancy O, Jeziorska M, Laing I., Yates AP, Pemberton PW, Malik RA, Heagerty AM. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation. 2009; 119: 1661-1670.
18. Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev. 2008; 60: 418-469.
19. Wang D, Chabrashvili T, Wilcox CS Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thrombox-ane prostanoid receptors, and endothelium. Circ Res. 2004; 94: 1436-1442. (Pubitemid 38786447)
20. Ji H, Zheng W, Menini S., Pesce C, Kim J, Wu X., Mulroney SE, Sandberg K. Female protection in progressive renal disease is associated with estra-diol attenuation of superoxide production. Gend Med. 2007; 4: 56-71. (Pubitemid 46917068)
21. Modlinger P, Chabrashvili T, Gill P.S., Mendonca M., Harrison DG, Griendling KK, Li M, Raggio J., Wellstein A, Chen Y, Welch WJ, Wilcox CS. RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension. 2006; 47: 238-244. (Pubitemid 43189769)
22. Heagerty AM, Aalkjaer C, Bund S.J., Korsgaard N., Mulvany MJ Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension. 1993; 21: 391-397. (Pubitemid 23095149)
23. Wong CM, Yao X, Au C.L., Tsang SY, Fung KP, Laher I, Vanhoutte P.M., Huang Y. Raloxifene prevents endothelial dysfunction in aging ovariecto-mized female rats. Vascul Pharmacol. 2006; 44: 290-298.
24. Widder J, Pelzer T, von Poser-Klein C, Hu K, Jazbutyte V, Fritzemeier KH, Hegele-Hartung C, Neyses L, Bauersachs J. Improvement of endo-thelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR. Hypertension. 2003; 42: 991-996. (Pubitemid 37413743)
25. Squadrito F, Altavilla D, Squadrito G., Saitta A, Cucinotta D, Minutoli L., Deodato B, Ferlito M, Campo GM, Bova A, Caputi AP. Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res. 2000; 45: 454-462. (Pubitemid 30069511)
26. Szasz T, Bomfim GF, Webb RC The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag. 2013; 9: 105-116.
27. Samuni Y, Cook JA, Choudhuri R, Degraff W., Sowers AL, Krishna MC, Mitchell JB Inhibition of adipogenesis by Tempol in 3T3-L1 cells. Free Radic Biol Med. 2010; 49: 667-673.
28. Huang A, Sun D, Koller A. Shear stress-induced release of prostaglandin H2 in arterioles of hypertensive rats. Hypertension. 2000; 35: 925-930. (Pubitemid 30303952)
29. Wang D, Wang X, Welch W.J., Ji H., Sandberg K, Wu X, Jose P., Wilcox CS. Endothelin is a potent endothelium-derived contracting factor released by the renal afferent arterioles and mesenteric resistance vessels of mice with prolonged oxidative stress due to EC-SOD knockout. J Am Soc Nephrol. 2006; 17: 716A. Abstract
30. Valentin F, Field MC, Tippins Jr The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells. J Biol Chem. 2004; 279: 8316-8324. (Pubitemid 38294723)
31. Kawada N, Dennehy K, Solis G., Modlinger P, Hamel R, Kawada J.T., Aslam S., Moriyama T, Imai E, Welch WJ, Wilcox CS. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am J Physiol Renal Physiol. 2004; 287:F753-F759. (Pubitemid 39280511)
32. Wilson SJ, Cavanagh CC, Lesher A.M., Frey AJ, Russell SE, Smyth EM Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species. J Lipid Res. 2009; 50: 1047-1056.
33. Kuzkaya N, Weissmann N, Harrison D.G., Dikalov S. Interactions of peroxyni-trite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem. 2003; 278: 22546-22554. (Pubitemid 36830310)
34. Welch WJ, Patel K, Modlinger P., Mendonca M, Kawada N, Dennehy K., Aslam S, Wilcox CS. Roles of vasoconstrictor prostaglandins, COX-1 and -2, AT1, AT2 and TP receptors in a rat model of early 2K, 1C hypertension. Am J Physiol. 293:H2644-H2649.
35. Schildknecht S, van der Loo B, Weber K, Tiefenthaler K, Daiber A, Bachschmid MM. Endogenous peroxynitrite modulates PGHS-1-dependent thromboxane A2 formation and aggregation in human platelets. Free Radic Biol Med. 2008; 45: 512-520.